blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3634430

EP3634430 - MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  05.07.2024
Database last updated on 05.08.2024
FormerGrant of patent is intended
Status updated on  30.01.2024
FormerExamination is in progress
Status updated on  16.09.2022
FormerRequest for examination was made
Status updated on  13.03.2020
FormerThe international publication has been made
Status updated on  15.12.2018
Most recent event   Tooltip05.07.2024(Expected) grantpublished on 07.08.2024 [2024/32]
Applicant(s)For all designated states
Flagship Pioneering Innovations V, Inc.
55 Cambridge Parkway, 8th Floor
Cambridge, MA 02142 / US
[2020/16]
Inventor(s)01 / CASEY, Jr., John Patrick
1 Goodwin Place 4
Boston, MA 02114 / US
02 / BERRY, David
155 Beethoven Avenue
Waban, MA 02468 / US
03 / CASTRO, Alfredo
14 Kelly Drive
Woburn, MA 01801 / US
04 / TAYLOR, Steven J.
17 Hill Street
Winchester, MA 01890 / US
05 / MASSARI, Ferdinand E.
33 Crescent Avenue
Beverly, MA 01915 / US
06 / PROUDFOOT, John
40 Currituck Road
Newtown, CT 06470 / US
07 / BOGART, Elijah
27 Putnam Avenue 2
Cambridge, MA 02139 / US
08 / BRIGGS, Timothy F.
105 Vernon Street
Unit 2
Waltham, MA 02453 / US
 [2020/16]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[2024/32]
Former [2020/16]Dörner, Eva Charlotte
Maiwald Patentanwalts- und
Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
Application number, filing date18814051.105.06.2018
[2020/16]
WO2018US36113
Priority number, dateUS201762515409P05.06.2017         Original published format: US 201762515409 P
US201862613359P03.01.2018         Original published format: US 201862613359 P
US201862632531P20.02.2018         Original published format: US 201862632531 P
[2020/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018226732
Date:13.12.2018
Language:EN
[2018/50]
Type: A1 Application with search report 
No.:EP3634430
Date:15.04.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 13.12.2018 takes the place of the publication of the European patent application.
[2020/16]
Type: B1 Patent specification
No.:EP3634430
Date:07.08.2024
Language:EN
[2024/32]
Search report(s)International search report - published on:US13.12.2018
(Supplementary) European search report - dispatched on:EP15.03.2021
ClassificationIPC:A61K31/7034, A61K31/05, A61K31/09, A61K31/122, A61K31/137, A61K31/14, A61K31/155, A61K31/353, A61K31/366, A61K31/606, A61P13/12, A61P43/00, A61K47/54, C07C403/24
[2024/08]
CPC:
A61P13/12 (EP); A61K31/353 (EP,KR); A61K31/155 (EP,KR,US);
A23L33/11 (US); A61K31/05 (EP); A61K31/09 (EP);
A61K31/12 (KR); A61K31/122 (EP); A61K31/137 (EP);
A61K31/14 (EP); A61K31/164 (US); A61K31/192 (US);
A61K31/196 (KR); A61K31/197 (US); A61K31/203 (KR);
A61K31/205 (US); A61K31/355 (US); A61K31/366 (EP,US);
A61K31/37 (KR); A61K31/375 (KR,US); A61K31/397 (KR);
A61K31/592 (US); A61K31/606 (EP); A61K31/702 (US);
A61K31/7034 (EP,KR); A61K31/7068 (KR); A61K31/728 (US);
A61K38/063 (KR); A61K38/08 (US); A61K47/54 (EP);
A61K47/549 (EP); A61K9/0014 (US); A61K9/0029 (US);
A61K9/0053 (US); A61K9/1623 (US); A61P1/16 (KR);
A61P17/00 (KR); A61P21/00 (KR); A61P29/00 (KR);
A61P3/10 (KR); A61P43/00 (EP); A61P9/00 (KR);
C07C403/24 (EP); A61K2300/00 (KR); A61K45/06 (US) (-)
C-Set:
A61K31/05, A61K2300/00 (EP);
A61K31/09, A61K2300/00 (EP);
A61K31/122, A61K2300/00 (EP);
A61K31/137, A61K2300/00 (EP);
A61K31/14, A61K2300/00 (EP);
A61K31/155, A61K2300/00 (EP);
A61K31/353, A61K2300/00 (EP);
A61K31/366, A61K2300/00 (EP);
A61K31/606, A61K2300/00 (EP);
A61K31/7034, A61K2300/00 (EP)
(-)
Former IPC [2021/15]A61K31/7034, A61P13/12, A61K31/606, A61K31/366, A61P43/00, A61K31/353, A61K31/05, A61K31/09, A61K31/122, A61K31/137, A61K31/14, A61K31/155
Former IPC [2020/16]A61K31/7034, A61P13/12
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/16]
Extension statesBA02.01.2020
ME02.01.2020
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:MULTIBIOTIKA UND VERWENDUNGSVERFAHREN DAFÜR[2020/16]
English:MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME[2020/16]
French:AGENTS MULTIBIOTIQUES ET PROCÉDÉS D'UTILISATION DE CEUX-CI[2020/16]
Entry into regional phase02.01.2020National basic fee paid 
02.01.2020Search fee paid 
02.01.2020Designation fee(s) paid 
02.01.2020Examination fee paid 
Examination procedure02.01.2020Examination requested  [2020/16]
29.10.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
07.01.2022Amendment by applicant (claims and/or description)
20.09.2022Despatch of a communication from the examining division (Time limit: M06)
29.03.2023Reply to a communication from the examining division
31.01.2024Communication of intention to grant the patent
28.05.2024Fee for grant paid
28.05.2024Fee for publishing/printing paid
28.05.2024Receipt of the translation of the claim(s)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
07.01.2022Request for further processing filed
07.01.2022Full payment received (date of receipt of payment)
Request granted
18.01.2022Decision despatched
Fees paidRenewal fee
29.06.2020Renewal fee patent year 03
28.06.2021Renewal fee patent year 04
27.06.2022Renewal fee patent year 05
27.06.2023Renewal fee patent year 06
27.06.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]US2012230955  (EKHART PETER FRANK [BE], et al);
 [XI]US2016213702  (VON MALTZAHN GEOFFREY A [US], et al)
International search[Y]US5677340  (YU RUEY J [US], et al) [Y] 321 * ; abstract *;
 [Y]US6784177  (COHN JAY N [US], et al) [Y] 318 * ; abstract *;
 [Y]US2004265345  (PERRICONE NICHOLAS V [US]) [Y] 7 * ; abstract *;
 [Y]WO2005000248  (GERON CORP [US], et al) [Y] 317 * ; pg. 3, In 9-11, pg. 4, In 5 *;
 [Y]US2010310615  (VERCAUTEREN JOSEPH [FR]) [Y] 5, 316 * ; para [0001], [0040] *;
 [XY]US2012010284  (BEZWADA RAO S [US]) [X] 1, 2, 4, 8, 311-313, 315, 323 * ; para [0002]-[0003], [0010][0011], [0019], [0024], [0064], [0073], [0091] * [Y] 5-7, 314, 316-322, 324;
 [Y]US8388939  (FOURNIAL ARNAUD [FR], et al) [Y] 319 * ; col 2, In 11-12, abstract *;
 [Y]WO2013142279  (SEACHAID PHARMACEUTICALS INC [US]) [Y] 322 * ; pg. 2, In 33-35, pg. 18, In 20-22 *;
 [XY]WO2016025668  (UNIV CALIFORNIA [US]) [X] 1-3, 64-65 * ; para [0003], [0012], [0021]-[0022], figure 27 * [Y] 320;
 [Y]  - JANIKULA Mark, "Policosanol: A New Treatment for Cardiovascular Disease?", Alternative Medicine Review: A journal of clinical therapeutic, (20020600), vol. 7, no. 3, pages 203 - 217, XP055562247 [Y] 6 * ; pg. 203, abstract *
 [Y]  - LIN et al., "Improving the Stability of Astaxanthin by Microencapsulation in Calcium Alginate Beads", PLOS ONE, (20160419), vol. 11, no. 4, pages 1 - 10, XP055562248 [Y] 314 * Pg. 1, para 1, abstract *

DOI:   http://dx.doi.org/10.1371/journal.pone.0153685
 [Y]  - HWANG et al., "Antifungal Effect of (+)-Pinoresinol Isolated from Sambucus williamsii", Molecules, (20100514), vol. 15, no. 5, pages 3507 - 3516, XP055562252 [Y] 324 * Pg. 3507, abstract *

DOI:   http://dx.doi.org/10.3390/molecules15053507
by applicantUS5112598
 US5556611
 US2012010284
 US2012230955
 WO2016025668
 US2016213702
    - MAURER et al., PLoS ONE, (20150000), vol. 10, page e0129076
    - SINGH, Immunity, (20140000), vol. 40, pages 128 - 39
    - YAMASHITA et al., Circ J., (20150000), vol. 79, pages 1882 - 90
    - ZHANG et al., Nutr Cancer., (20100000), vol. 62, no. 1, pages 1 - 20
    - UNGVARI et al., Am J Physiol Heart Circ Physiol., (20090000), vol. 297, no. 5, pages H1876 - 81
    - CHEN, Biochem Biophys Res Commun., (20160000), vol. 481, no. 1-2, pages 63 - 70
    - TOLHURST, Diabetes., (20020000), vol. 61, no. 2, pages 364 - 71
    - CHAMBERS, Proc Nutr Soc., (20150000), vol. 74, no. 3, pages 328 - 36
    - HAN, Exp Mol Med., (20030000), vol. 35, no. 2, pages 136 - 9
    - QIN, J Immunol., (20110000), vol. 186, no. 6, pages 3693 - 700
    - WONG, Immunol Lett., (20110000), vol. 139, no. 1-2, pages 7 - 13
    - FARRNNINMARI, J., Hypertens.,, (19980000), vol. 16, pages 895 - 906
    - RABOL et al., Proc. Nat. Acad. Sci., (20110000), vol. 108, pages 13705 - 13709
    - ZELANTE, Immunity., (20130000), vol. 39, no. 2, pages 372 - 85
    - STRATTON, J Clin Nutr, (20060000), vol. 84, pages 384 - 8
    - BARTON et al., Gut, (20170000), vol. 0, pages 1 - 9
    - TROMBOLD, Medicine and Science in sports and exercise, (20100000), page 493
    - RYU, Nature Medicine, (20160000), vol. 22, pages 879 - 888
    - ABRAHAMSSON, J Allergy Clin Immunol., (20120000), vol. 129, no. 2, pages 434 - 40
    - TUNDIS, Curr. Med. Chem., (20150000), vol. 22, pages 1515 - 1538
    - HAGHIKIA, Immunity, (20150000), vol. 43, pages 819 - 29
    - ROY, Nat Rev Cancer, (20170000), vol. 17, pages 271 - 285
    - MOUNDHRI, J Med Toxicol, (20130000), vol. 9, pages 25 - 33
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.